National Bank of Canada
SEEL

National Bank of Canada’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

National Bank of Canada’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$2 – 3093
2024
Q2 		– Hold
0
– – – 2684
2024
Q1 		– Hold
0
– – – 2707
2023
Q4 		– Hold
0
– – – 2671
2023
Q3 		– Hold
0
– – – 2700
2023
Q2 		– Hold
0
– – – 2534
2023
Q1 		– Hold
0
– – – 2567
2022
Q4 		– Hold
0
– – – 2624
2022
Q3 		– Hold
0
– – – 2653
2022
Q2 		– Hold
0
– – – 2740
2022
Q1 		– Hold
0
– – – 2816
2021
Q4 		– Hold
0
– – – 2708

Other funds holding SEEL

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CHA
Carmichael Hill & Associates Gaithersburg, Maryland $282M AUM 32.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return